Company Respirerx Pharmaceuticals Inc Other OTC
Equities
US2205243007
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 21/03/13 |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 21/03/13 |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 14/10/14 |
David Dickason
PRN | Corporate Officer/Principal | - | 14/09/20 |
Marc M. Radin
AUD | Comptroller/Controller/Auditor | - | 30/09/13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 21/03/13 |
Director/Board Member | - | 21/03/23 | |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 21/03/13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 365,418,647 | 341,184,734 ( 93.37 %) | 0 | 93.37 % |
Stock B | 0 | 37,500 | 0 | 0 |
Company contact information
RespireRx Pharmaceuticals, Inc.
126 Valley Road Suite C
07452, Glen Rock
+201 444 4947
http://www.respirerx.comSector
1st Jan change | Capi. | |
---|---|---|
+7.68% | 111B | |
+11.16% | 106B | |
-12.27% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.61% | 16.81B | |
+38.95% | 12.54B | |
-24.43% | 8.09B |
- Stock Market
- Equities
- RSPI Stock
- Stock
- Company Respirerx Pharmaceuticals Inc